Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MD
MD logo

MD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Pediatrix Medical Group Inc (MD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
23.520
1 Day change
-0.38%
52 Week Range
24.990
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Pediatrix Medical Group Inc (MD) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock shows some positive technical indicators and modest price target increases from analysts, there are no significant catalysts or trading signals to suggest immediate upside potential. Additionally, there is no recent news or financial data to support a compelling investment case.

Technical Analysis

The stock's technical indicators are moderately positive. The MACD histogram is above 0 and positively contracting, suggesting a bullish trend. The RSI is neutral at 54.129, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at $24.476 and $25.033, with support at $22.673 and $22.116.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
7

Positive Catalysts

  • Analysts have raised price targets recently, with Jefferies giving a Buy rating and a target of $

  • Bullish moving averages indicate a positive trend.

  • The stock has an 8.27% chance of increasing in the next month based on historical patterns.

Neutral/Negative Catalysts

  • No recent news or event-driven catalysts.

  • Hedge funds and insiders are neutral, with no significant trading activity.

  • Lack of strong trading signals from Intellectia Proprietary Trading Signals.

Financial Performance

No financial data available for the latest quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have raised price targets modestly, with UBS, Mizuho, and Truist maintaining Neutral or Hold ratings. Jefferies is the only firm with a Buy rating and a $27 price target.

Wall Street analysts forecast MD stock price to fall
3 Analyst Rating
Wall Street analysts forecast MD stock price to fall
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 23.610
sliders
Low
23
Averages
23.5
High
24
Current: 23.610
sliders
Low
23
Averages
23.5
High
24
UBS
Neutral
maintain
$22 -> $25
AI Analysis
2026-05-12
Reason
UBS
Price Target
$22 -> $25
AI Analysis
2026-05-12
maintain
Neutral
Reason
UBS raised the firm's price target on Pediatrix Medical to $25 from $22 and keeps a Neutral rating on the shares.
Mizuho
Neutral
maintain
$21 -> $24
2026-05-08
Reason
Mizuho
Price Target
$21 -> $24
2026-05-08
maintain
Neutral
Reason
Mizuho raised the firm's price target on Pediatrix Medical to $24 from $21 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MD
Unlock Now

People Also Watch